Bosh sahifaTWST • NASDAQ
add
Twist Bioscience Corp
54,92 $
Seans yopilganidan keyin:(0,80%)-0,44
54,48 $
Yopilgan:18-fev, 20:00:00 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
52,88 $
Kunlik diapazon
52,48 $ - 57,88 $
Yillik diapazon
23,30 $ - 57,88 $
Bozor kapitalizatsiyasi
3,37 mlrd USD
Oʻrtacha hajm
1,52 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 103,70 mln | 16,89% |
Joriy xarajat | 86,87 mln | 12,12% |
Sof foyda | -30,51 mln | 3,44% |
Sof foyda marjasi | -29,42 | 17,38% |
Har bir ulushga tushum | -0,50 | 5,66% |
EBITDA | -27,01 mln | 5,45% |
Amaldagi soliq stavkasi | -0,84% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 197,95 mln | -26,91% |
Jami aktivlari | 638,08 mln | 4,85% |
Jami passivlari | 181,99 mln | 19,23% |
Umumiy kapital | 456,10 mln | — |
Tarqatilgan aksiyalar | 61,31 mln | — |
Narxi/balansdagi bahosi | 7,11 | — |
Aktivlardan daromad | -12,85% | — |
Kapitaldan daromad | -14,52% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -30,51 mln | 3,44% |
Operatsiyalardan naqd pul | -24,81 mln | -15,80% |
Sarmoyadan naqd pul | -9,93 mln | -546,68% |
Moliyadan naqd pul | 298,00 ming | -98,34% |
Naqd pulning sof oʻzgarishi | -34,44 mln | -578,89% |
Boʻsh pul | -25,86 mln | -130,04% |
Haqida
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Tashkil etilgan
2013
Xodimlar soni
979
